Defining ‘Intention’ in intention-to-treat survival outcomes for chimeric antigen receptor T-cell therapy
Saved in:
Main Authors: | Charles J. Milrod, Rebecca Steuer, Ari Pelcovits |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2025-02-01
|
Series: | Blood Cancer Journal |
Online Access: | https://doi.org/10.1038/s41408-025-01220-0 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Capivasertib enhances chimeric antigen receptor T cell activity in preclinical models of B cell lymphoma
by: Hui-Ju Hsieh, et al.
Published: (2025-03-01) -
Advancing Multiple Myeloma Immunotherapy: A Review of Chimeric Antigen Receptor T-Cell and Bispecific T-Cell Engagers Cell Therapies in Revolutionizing Treatment
by: Rahul Navab, et al.
Published: (2025-01-01) -
Development of a TCR-like antibody and chimeric antigen receptor against NY-ESO-1/HLA-A2 for cancer immunotherapy
by: Xin Liu, et al.
Published: (2022-03-01) -
The nature of legislative intent /
by: Ekins, Richard
Published: (2012) -
Understanding participation intention and word-of-mouth intention in voter contact: A framework based on the theory of planned behaviour
by: Nguyễn Thanh Nhàn
Published: (2025-01-01)